Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News electroCore, Inc. ECOR

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS... see more

Recent & Breaking News (NDAQ:ECOR)

gammaCore™ Now Available Through U.S. Federal Government’s Federal Supply Schedule (FSS)

GlobeNewswire January 2, 2019

electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults

GlobeNewswire November 28, 2018

electroCore Expands Manufacturing Capabilities for gammaCore™

GlobeNewswire November 27, 2018

electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference

GlobeNewswire November 20, 2018

electroCore, Inc. Announces Third Quarter Financial Results

GlobeNewswire November 13, 2018

NICE publishes advice on gammaCore for the treatment of cluster headache in the UK

GlobeNewswire November 9, 2018

electroCore, Inc. to Report Third Quarter Financial Results on November 13, 2018

GlobeNewswire October 30, 2018

electroCore, Inc. Announces Appointment of Ardelle Ferris as Vice President of Managed Care

GlobeNewswire October 30, 2018

electroCore, Inc. to Present at the Cantor Global Healthcare Conference

GlobeNewswire September 18, 2018

electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation in Headache Disorders at the 17th Biennial Migraine Trust International Symposium

GlobeNewswire September 5, 2018

electroCore, Inc. Announces Second Quarter Financial Results

GlobeNewswire August 13, 2018

electroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-Invasive Vagus Nerve Stimulation in Neuroinflammation

GlobeNewswire August 9, 2018

Next Generation nVNS Therapy gammaCore Sapphire™ Now Available for Patients with Migraine and Episodic Cluster Headache in United States

GlobeNewswire August 1, 2018

electroCore, Inc. to Report Second Quarter Financial Results on August 13, 2018

GlobeNewswire July 26, 2018

electroCore and UpScript Launch Program to Offer Direct-to-Patient Telemedicine Option for gammaCore™ in the United States

GlobeNewswire July 17, 2018

electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering

GlobeNewswire July 10, 2018

electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation (nVNS) in Headache Disorders at the 60th Annual Meeting of the American Headache Society

GlobeNewswire June 28, 2018

electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

GlobeNewswire June 28, 2018

electroCore, Inc. Announces Closing of Initial Public Offering

GlobeNewswire June 26, 2018

electroCore, Inc. Announces Pricing of Initial Public Offering

GlobeNewswire June 21, 2018